نگاهی به ژن درمانی، پیشرفتهای اخیر و چشم انداز آینده
Authors
Abstract:
Human gene therapy has attracted increasing attention as a highly encouraging therapeutic approach to treat wide variety of diseases, other than genetically inherited and monogenic disorders. This approach entails the introduction and expression of a variety of nucleic acids into human target cells for therapeutic purposes. In this article, we review the history, highlights, recently progresses and future of gene therapy approaches. The first gene therapy clinical trial was successfully performed in 1990s for treating an inherited genetic disorder, Severe Combined Immunodeficiency (SCID). Subsequently, the number of gene therapy clinical trials was exponentially continued to increase over the years. However, the initial results of these trials did not meet expectations. In the last decade, due to improvements in the gene transfer vectors, the dreams of treating severe immunodeficiency and genetic disorders and cancer by gene therapy products is again closer to reality. Before gene therapy becomes an extensively accepted approach for treating wide range of diseases, some limitative intracellular and extracellular barriers need to be overcome. Currently, a wide range of gene delivery vectors have been developed to do this. A number of safe viral vectors and non-viral methods were innovated and used for successfully treatment of some inherited and immune deficiencies, ocular diseases and cancer. Viral gene delivery vectors are appropriate for gene therapy purposes which are based on long-term gene expression. Although, non-viral vectors are less efficient than former in gene transduction, they have utilities owing to their high target cell specificity, low immunogenicity and ability to transfer large size genes. In conclusion, recent progress in the gene therapy approaches is somewhat realizing expectancies made many years ago, providing bright hopefulness for further achievements in the next years. Gene therapy appears to be final selective approach for the treatment of many human diseases in this century.
similar resources
سندرم شوگرن - ژن درمانی و چشم انداز
Sjogren syndrome is one of the autoimmune diseases which is characterized by lymphocytic infiltration to exocrine glands and causes keratoconjunctivitis sicca and xerostomia. Today, a large population, with a majority of women over 40, suffer from this disease and have several complications regarding oral health and reduced life quality such as severe dental caries, painful eyes, olfactory and ...
full textچشم انداز آینده (قسمت اول)
مانایى، پایایى و پویایى هر مکتب و اندیشه اى به عوامل مختلف و متعددى بستگى دارد. از جمله مهم ترین این عوامل رفتار پیروان و معتقدان آن مکتب است. به عبارت روشن تر، کنش و عمل پیروان یک مکتب بر پویایى و پایایى آن مکتب تأثیر بسزایى دارد. مکتب اسلام از بدو پیدایش تاکنون روشنایى و نور را براى پیروان خود به ارمغان آورده است، این مکتب با تکیه بر عناصرى چون تدبّر و تعمق در کائنات هستى و کاوش شناخت و معر...
full textسندرم شوگرن - ژن درمانی و چشم انداز
سندرم شوگرن از جمله بیماریهای خود ایمنی است که با ارتشاح لنفوسیتی به غدد برون ریز مشخص می گردد و موجب کراتوکنژکتویت سیکا و خشکی دهان می شود. در حال حاضر جمعیت بسیاری که اغلب آنها را زنان بالای چهل سال تشکیل می دهند از این بیماری رنج می برند و با مشکلات متعددی از جهت سلامت دهان و دندان و کاهش کیفیت زندگی، مانند پوسیدگیهای شدید دندانی، چشمانی دردناک، نواقص بویایی و چشایی، تکلم، جویدن و بلع مواجه ...
full textMy Resources
Journal title
volume 23 issue 149
pages 28- 45
publication date 2016-11
By following a journal you will be notified via email when a new issue of this journal is published.
No Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023